SME Times is powered by   
Search News
Just in:   • Equity indices break two-day losing streak on value buying  • IMF urges Sri Lanka to tighten monetary policy  • Global semiconductor sales to reach $676 bn this year: Gartner  • Tinna Rubber hits upper circuit, investors accumulate 900% returns in year  • Availability of jobs in Japan improves for 1st time in 3 yrs 
Last updated: 27 Sep, 2014  

India Pharma Awards Announces 2014 Jury

PR Newswire | 26 Aug, 2014
MUMBAI: UBM India announced the jury panel for the second edition of its India Pharma Awards. Recognizing leading innovators across 9 categories, the India Pharma Awards acknowledge innovation and excellence in the Indian pharmaceutical industry, thus creating an industry platform to celebrate the contribution of the key players amongst their Indian and international fraternity.
Against the backdrop of the global pharma industry increasingly looking at India for higher quality and low-cost pharma solutions, the India Pharma Awards celebrates the thinkers and creators who consistently break new ground in the pharma sector, thereby taking the value chain to its next level.

UBM India is proud to have on board, distinguished and renowned jury members from the industry. The jury panel for 2014 India Pharma Awards will be chaired by:

- Dr. Sudarshan Jain, Managing Director, Abbott Healthcare Solutions

- Dr. Ajit Dangi, President and CEO, Danssen Consulting

- Dr. Safia Rizvi, Managing Director, UCB India Private Ltd

- Mr. Devinder Pal, President, Catalyst Pharma Consulting

- Mr. S V Veerramani, Founder & Chairman, Fourrts (India) & President, IDMA.

Commenting on the sidelines of the announcement, Mr. Joji George, Managing Director, UBM India said, "The consent of such an esteemed panel to be associated with the awards further validates the industry need and acceptance of such a platform in India, to acknowledge and recognize the contribution of pharma companies."

The 2nd annual India Pharma Awards is slated for 1st December 2014 at The Westin Garden City, Mumbai. The event which will be attended by more than 300 decision makers from across the industry; India's pharma machinery, technology, ingredients, outsourcing and biopharma industry, will also witness participation of key officials from the ministries (Home, Food & Drug Dept).

India Pharma Awards provides a high impact platform for companies to achieve significant product and brand exposure pre, during and post the event. It presents a range of partnering opportunities available to compliment your company's existing marketing mix, allowing you to generate months of publicity and gain direct access to top decision makers within the Indian pharmaceutical community. For more details:

For further information on partnering opportunities please contact: Jayesh Kanaskar on +91-22-61727173 or email:

About UBM India

UBM India is India's leading live media and events company that engages people and enriches businesses. We at UBM India provide the industry with platforms that bring together buyers and sellers from around the world, through a portfolio of exhibitions, content led conferences and seminars, tech media, live events, data services and powerful media brands. UBM India hosts over 20 large scale exhibitions and 40 conferences across the country every year, thereby enabling trade across multiple industry verticals. A UBM Asia Company, UBM India has offices across Mumbai, New Delhi, Bangalore and Chennai. UBM Asia is owned by UBM plc which is listed on the London Stock Exchange. UBM Asia is the leading exhibition organiser in Asia and the biggest commercial organiser in mainland China, India and Malaysia. For further details, please visit

Primary Media Contact: Priya Badshah,, +91-9052578641, Head - PR, UBM India

Secondary Media Contact: Arnab Das,, +91-9167394888, Group Manager, Madison India

Print the Page Add to Favorite
Share this on :

Please comment on this story:
Subject :
(Maximum 1500 characters)  Characters left 1500
Your name:

  Customs Exchange Rates
Currency Import Export
US Dollar
UK Pound
Japanese Yen 58.85 56.85
As on 27 Apr, 2022
  Daily Poll
COVID-19 has directly affected your business
 Can't say
  Commented Stories
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter